Current Size: 100%

Media & PR

A life dedicated to trauma research


Head of the institute, chair of TERMIS Europe, founder of the Austrian Cluster for Tissue Regeneration…. Heinz Redl has achieved a lot in his scientific career - and is far from done yet. In an interview with he looks back at the greatest successes and gives insights into his fascination with tissue regeneration and the future of trauma research. The article was published in the current issue and is accessible online here (German only).

COVID19 report on ORF2


Johannes Zipperle, molecular biologist at LBI Trauma and expert on public health, was invited to Studio2 on ORF2 to talk about the measures in Austria, reports from colleagues in Milano, and how medical care can be ensured for patients with and without COVID-19.

The Competence Center for MechanoBiology: A Czech-Austrian success story


As part of an Interreg program, the Competence Center for MechanoBiology enables cross-border cooperation between Austrian and Czech institutes. LBI Trauma is among the three Austrian members. Together, the scientists examine how mechanical forces act on tissues and cells, what signals are triggered within and surrounding the cells and how this can be used to stimulate healing.

New guidelines for sepsis studies - MQTiPSS are gaining attention


The incidence of sepsis is on the rise worldwide. Despite continuous improvements of diagnosis and treatment, one out of four hospitalized septic patients dies of the condition. While patient management is organized by up-to-date guidelines, the translation of new research findings into the clinics is hampered by the lack of best practices and standardization in preclinical sepsis studies. With large quality gaps as well as conflicting data, scientists struggle to reconcile the pre-existing and emerging experimental findings into coherent blueprints of sepsis pathophysiology.

The dream of walking – ESWT makes headlines

Originally used for treating kidney stones, extracorporeal shock wave treatment (ESWT) has extended its range of applications. Beneficial effects on bone fractures, chronic wounds and neural defects have been observed. The latter lead to the idea of ESWT for spinal cord injuries.

The results obtained at the LBI Trauma are promising – soon patients will be treated in course of the first clinical study.

Decreased death rate due to improved coagulation


Coagulopathies – conditions in which the blood’s ability to form clots is impaired – occur in one quarter of patients at the intensive care unit, with often life-threatening consequences. They are caused by high blood loss or reactions following systemic shock, but also previous intake of anticoagulants. Hemostasis and wound closure are vitally important as soon as possible after injury. To counteract coagulopathies blood transfusion in high amounts used to be the treatment of choice. However, blood products are valuable (because essential for the treatment of certain pathologies) and may cause unwanted side effects.